Your browser doesn't support javascript.
loading
Systemic interferon type I and type II signatures in primary Sjögren's syndrome reveal differences in biological disease activity.
Bodewes, Iris L A; Al-Ali, Shereen; van Helden-Meeuwsen, Cornelia G; Maria, Naomi I; Tarn, Jessica; Lendrem, Dennis W; Schreurs, Marco W J; Steenwijk, Eline C; van Daele, Paul L A; Both, Tim; Bowman, Simon J; Griffiths, Bridget; Ng, Wan-Fai; Versnel, Marjan A.
Afiliación
  • Bodewes ILA; Department of Immunology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Al-Ali S; Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • van Helden-Meeuwsen CG; Department of Biology, College of Science, University of Basrah, Basrah, Iraq.
  • Maria NI; Department of Immunology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Tarn J; Department of Immunology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Lendrem DW; Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Schreurs MWJ; Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Steenwijk EC; Department of Immunology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • van Daele PLA; Department of Immunology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Both T; Department of Immunology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Bowman SJ; Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands.
  • Griffiths B; Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands.
  • Ng WF; Rheumatology Department, University Hospital Birmingham, Birmingham, UK.
  • Versnel MA; Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Rheumatology (Oxford) ; 57(5): 921-930, 2018 05 01.
Article en En | MEDLINE | ID: mdl-29474655

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ARN / Interferón Tipo I / Síndrome de Sjögren / Regulación de la Expresión Génica / Interferón gamma Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ARN / Interferón Tipo I / Síndrome de Sjögren / Regulación de la Expresión Génica / Interferón gamma Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos
...